1887
Volume 2026, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Vaccine-preventable diseases (VPDs) remain a public-health concern in Qatar despite high immunization coverage. Frequent population movement and incomplete vaccination records may lead to susceptibility clusters and under-reporting. These dynamics underline the need for sustained surveillance and targeted immunization strategies. This study aims to assess the influence of geographical variation and age-specific demographics on VPD incidence among the Primary Health Care Corporation (PHCC)-registered population in Qatar to inform immunization planning and address emerging gaps.

A retrospective analysis of Qatar’s Ministry of Public Health surveillance data (2021–2024), supplemented by PHCC medical records, examined annual incidence rates of VPDs by age group and region. Cases included acute flaccid paralysis, chickenpox, mumps, measles, pertussis, rotavirus, and meningitis due to viral, , , , and bacterial non-meningococcal pathogens.

Between 2021 and 2024, 5136 confirmed VPD cases were reported among PHCC-registered individuals. Chickenpox was most frequent, peaking in 2023 (1398 cases). Incidence was highest in children under 5 years old, particularly infants, for chickenpox (145.75/100,000), measles (66.35), pertussis (59.95), and rotavirus (47.61). Viral meningitis was concentrated in infants, with the Western region recording the highest rate (70.02). Regionally, chickenpox burden was greatest in the Central region, while pertussis, rotavirus, and measles rates were highest in the Western region. No statistically significant differences were observed between regions or across study years (P > 0.05 for all comparisons).

Age-specific disparities in VPD incidence were noted in Qatar, with the highest burden among children under 5 years and in the Western region. Chickenpox was the most reported disease, followed by pertussis, rotavirus, and viral meningitis. No statistically significant differences were observed between regions, suggesting equitable immunization delivery across PHCC. These findings highlight the need to sustain high vaccination coverage, enhance parent-focused health education, strengthen surveillance to detect immunity gaps, and improve data linkage across PHCC, private providers, and national surveillance systems.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qmj.2026.4
٢٠٢٦-٠٣-٠٣
٢٠٢٦-٠٣-٠٣

القياسات

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2026/1/qmj.2026.4.html?itemId=/content/journals/10.5339/qmj.2026.4&mimeType=html&fmt=ahah

References

  1. World Health Organization . Immunization highlight: 2015. Geneva: World Health Organization; 2015. Available from: https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Apr2016/1_session_report_from_ivb/Apr2016_session1_immunization_highlights2015.pdf [cited December 20, 2021].
    [Google الباحث العلمي]
  2. Machingaidze S, Wiysonge CS, Hussey GD. Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med. 2013; 10:(3):e1001405. https://doi.org/10.1371/journal.pmed.1001405
    [Google الباحث العلمي]
  3. World Health Organization . World Immunization Week 2019. Geneva: World Health Organization; 2019. Available from: https://www.who.int/news-room/events/detail/2019/04/24/default-calendar/world-immunizationweek-2019 [cited December 21, 2021].
    [Google الباحث العلمي]
  4. World Health Organization . Global vaccine action plan. Monitoring, evaluation & accountability. Secretariat annual report 2017. Geneva. World Health Organization; 2017. Available from: https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Apr2016/1_session_report_from_ivb/Apr2016_session1_immunization_highlights2015.pdf [cited December 20, 2021].
    [Google الباحث العلمي]
  5. Sodha SV, Dietz V. Strengthening routine immunization systems to improve global vaccination coverage. Br Med Bull. 2015 Mar; 113:(1):5–14. https://doi.org/10.1093/bmb/ldv001
    [Google الباحث العلمي]
  6. Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, et al. Vaccine strategies: optimising outcomes. Vaccine. 2016 Dec; 34:(52):6691–9. https://doi.org/10.1016/j.vaccine.2016.10.078
    [Google الباحث العلمي]
  7. Sacre A, Sowden S, Bambra C, Bennett N, Todd A. COVID-19 and regional inequalities in childhood vaccination uptake in England: a spline regression. BMC Public Health. 2025 Aug; 25:(1):2913. https://doi.org/10.1186/s12889-025-24207-9
    [Google الباحث العلمي]
  8. Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA. 1983; 249:(9):1181–5. https://doi.org/10.1001/jama.1983.03330330059036
    [Google الباحث العلمي]
  9. Birkhead GS, Maylahn CM. State and local public health surveillance. Teutsch SM, Churchill RE Principles and Practice of Public Health Surveillance. New York: Oxford University Press; 2000.
    [Google الباحث العلمي]
  10. Primary Health Care Corporation . Annual Statistical Report 2024. Doha: Strategy Planning and Health Intelligence Directorate, Business and Health Intelligence Department; 2024.
    [Google الباحث العلمي]
  11. World Health Organization . WHO/UNICEF estimates of national immunization coverage. Geneva: World Health Organization; 2017. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/global-monitoring/immunization-coverage/who-unicef-estimates-of-national-immunization-coverage [cited December 21, 2021].
    [Google الباحث العلمي]
  12. Al-Dahshan A, Hammoud H, Chehab M, Osman SRO. Vaccination coverage in Qatar: benchmarking with global figures. Qatar Med J. 2019 Jul; 2019:(1):4. http://dx.doi.org/10.5339/qmj.2019.4
    [Google الباحث العلمي]
  13. Al-Kuwari MG, Al-Abdulla SA, Abdulla MY, Haj Bakri A, Mustafa Mohammed A, Chettiyam Kandy M, et al. Epidemiological health assessment in primary healthcare in the State of Qatar-2019. Qatar Med J. 2021 Oct; 2021:(3):57. https://doi.org/10.5339/qmj.2021.57
    [Google الباحث العلمي]
  14. Public Health Agency of Canada . Vaccine preventable diseases – surveillance report to December 2017. Ottawa: Public Health Agency of Canada; 2020. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/vaccines-immunization/vaccine-preventable-disease-surveillance-report-december-31-2017/vaccine-preventable-disease-surveillance-report-eng.pdf [cited December 21, 2021].
    [Google الباحث العلمي]
  15. Bernal JL, Hobbelen P, Amirthalingam G. Burden of varicella complications in secondary care, England, 2004 to 2017. Euro Surveill. 2019 Oct; 24:(42): 1900233. https://doi.org/10.2807/1560-7917.ES.2019.24.42.1900233
    [Google الباحث العلمي]
  16. Primary Health Care Corporation . Population Health Profiling 2021. Doha: Primary Health Care Corporation; 2023.
    [Google الباحث العلمي]
  17. Al-Ayyadhi NH, Al-Qimlas LM, Al-Awadhin SS, Al-Shammari FJ, A. Al-Ghimlas FA, Hassan HA. Varicella trends in Kuwait; a successful control. Arch Epidemiol. 2024 Aug; 7:153. https://doi.org/10.29011/2577-2252.100153
    [Google الباحث العلمي]
  18. Al Kaabi N, Al Olama FMAS, Al Qaseer M, Al Ubaidani I, Dinleyici EC, Hayajneh WA, et al. The clinical and economic burden of varicella in the Middle East: a systematic literature review. Hum Vaccin Immunother. 2019 Sep; 16:(1):21–32. https://doi.org/10.1080/21645515.2019.1638726
    [Google الباحث العلمي]
  19. Shah HA, Meiwald A, Perera C, Casabona G, Richmond P, Jamet N. Global prevalence of varicella-associated complications: a systematic review and meta-analysis. Infect Dis Ther. 2024 Jan; 13:(1):79–103. https://doi.org/10.1007/s40121-023-00899-7
    [Google الباحث العلمي]
  20. World Health Organization . Varicella and herpes zoster vaccines: WHO position paper, June 2014. Weekly Epidemiological Record; 2014. Available from: https://iris.who.int/server/api/core/bitstreams/73cbb891-41a3-43a8-9a1b-3a50e1f5e658/content [cited June 1, 2024].
    [Google الباحث العلمي]
  21. Islam MI, Freeman J, Chadwick V, Martiniuk A. Healthcare avoidance before and during the COVID-19 pandemic among Australian youth: a longitudinal study. Healthcare (Basel). 2022 Jul; 10:(7):1261. https://doi.org/10.3390/healthcare10071261
    [Google الباحث العلمي]
  22. GBD 2019 Meningitis Antimicrobial Resistance Collaborators . Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023 Aug; 22:(8):685–711. https://doi.org/10.1016/S1474-4422(23)00195-3
    [Google الباحث العلمي]
  23. Kurup PJ, Al-Abri S, Al-Mahrooqi S, Al-Jardani A, Bawikar S, Al-Rawahi B, et al. Epidemiology of meningitis in Oman—implications for future surveillance. J Epidemiol Glob Health. 2018 Dec; 8:(3-4):231–5. https://doi.org/10.2991/j.jegh.2018.02.001
    [Google الباحث العلمي]
  24. Mount HR, Boyle SD. Aseptic and bacterial meningitis: evaluation, treatment, and prevention. Am Fam Physician. 2017 Sep; 96:(5):314–22.
    [Google الباحث العلمي]
  25. Centers for Disease Control and Prevention . Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Washington (DC): Public Health Foundation; 2021.
    [Google الباحث العلمي]
  26. Matar E, Mohamed AM, Ali GJ, Ali FS, Husain M, Moosa AK, et al. Epidemiological characteristics of mumps cases in the Kingdom of Bahrain from 2012 to 2022. Cureus. 2024 Dec; 16:(12):e76551. https://doi.org/10.7759/cureus.76551
    [Google الباحث العلمي]
  27. Betáková T, Svetlíková D, Gocník M. Overview of measles and mumps vaccine: origin, present, and future of vaccine production. Acta Virol. 2013; 57:(2):91–6. https://doi.org/10.4149/av_2013_02_91
    [Google الباحث العلمي]
  28. Al-Qahtani H, Al-Mousa R, Al-Zeidan A, Alghamdi E, Alharbi M. A measles outbreak in Riyadh in 2023: clinical and epidemiological characteristics. J Infect Dis Child. 2023; 12:(4):109–17.
    [Google الباحث العلمي]
  29. GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct; 396:(10258):1204–20. https://doi.org/10.1016/S0140-6736(20)30925-9
    [Google الباحث العلمي]
  30. World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) . Measles cases surge worldwide, infecting 10.3 million people in 2023. WHO/CDC Joint News Release, 14 November. Available from: https://www.who.int/news/item/14-11-2024-measles-cases-surge-worldwide--infecting-10.3-million-people-in-2023 [cited November 20, 2024].
    [Google الباحث العلمي]
  31. Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front Immunol. 2019 Jul; 10:1344. https://doi.org/10.3389/fimmu.2019.01344
    [Google الباحث العلمي]
  32. Primary Health Care Corporation (PHCC) . Corporate Strategic Plan 2024-2030. Doha: PHCC; 2024. Available from: https://www.phcc.gov.qa/docs/default-source/default-document-library/strategy-2024-2030-_v3.pdf [cited October 27, 2025].
    [Google الباحث العلمي]
  33. Planning and Statistics Authority . Population, Area and Population Density per Square Kilometre by Zone [dataset]. Qatar Open Data Portal; 2024. Available from: https://www.data.gov.qa/explore/dataset/population-area-and-population-density-per-square-kilometers-by-zone/ [cited October 30, 2025].
    [Google الباحث العلمي]
  34. Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population. Influenza Other Respir Viruses. 2021 May; 15:(3):361–70. https://doi.org/10.1111/irv.12847
    [Google الباحث العلمي]
  35. Aljoharah Algabbani O, AlOmeir O, Algabbani F. Vaccine hesitancy in the Gulf Cooperation Council countries. East Mediterr Health J. 2023; 29:(5):402–11. https://doi.org/10.26719/emhj.23.064
    [Google الباحث العلمي]
  36. Madi N, Altawalah H, Alfouzan W, Al-Nakib W, Al-Roumi E, Jeragh A. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy. J Med Virol. 2020 Aug; 92:(8):963–70. https://doi.org/10.1002/jmv.25665
    [Google الباحث العلمي]
/content/journals/10.5339/qmj.2026.4
Loading
/content/journals/10.5339/qmj.2026.4
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Research Article
الموضوعات الرئيسية age-specific incidencegeographic distributionPrimary Health Care Corporationpublic-health surveillanceQatar and Vaccine-preventable diseases

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error